to optimize the structure of IgG antibodies and to design related or new structures with additional functions. Since the first generation of... IgG1 antibodies reached the market in the late 1990s ...

Navrogen, Inc. has announced groundbreaking advancements in monoclonal antibody (mAb) and antibody-drug conjugate (ADC) ...